Related Experiment Video
Updated: Aug 1, 2026

11:57
Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
Published on: March 28, 2014
Superimposition-based protocol as a tool for determining bioactive conformations. II. Application to the GABA(A)
E Gálvez-Ruano1, I Iriepa, A Morreale
1Departamento de Química Orgánica, Universidad de Alcalá de Henares, Madrid, Spain. enrique.galvez@uah.es
Journal of Molecular Graphics & Modelling
|January 5, 2002
Summary
Researchers identified key molecular features of gamma-aminobutyric acid (GABA) receptor ligands. This study reveals two distinct bioactive conformations for the flexible GABA molecule, crucial for drug design.
Area of Science:
- Pharmacology
- Computational Chemistry
- Neuroscience
Background:
- The gamma-aminobutyric acid (GABA) receptor, specifically the A subtype, is a critical target for neurological drugs.
- Understanding the precise molecular interactions of GABA receptor ligands is essential for developing selective agonists and antagonists.
Purpose of the Study:
- To elucidate the pharmacophoric requirements of the GABA-A receptor using computational modeling.
- To identify distinct bioactive conformations of GABA and related molecules.
Main Methods:
- Utilized the natural templates (NT) superimposition method.
- Employed bicuculline, a competitive antagonist, as a reference template for superimposing known antagonists and agonists.
- Integrated experimental data to refine molecular models.
Main Results:
- Identified two key substructural fragments within bicuculline to classify ligands.
- Revealed two distinct bioactive conformations for the flexible GABA molecule based on superimposition analysis.
- Characterized specific torsional angles defining these extended (coplanar) and non-planar conformations.
Conclusions:
- The study provides critical insights into the structural basis of GABA-A receptor ligand activity.
- The identified conformations offer a foundation for the rational design of novel GABAergic drugs.
- This computational approach, guided by experimental data, effectively models ligand-receptor interactions.

